TODAY’S TRADEMARK – PHEBRA

The trademark of this company was registered in USPTO bearing registration number 3631559 on June 2, 2009.

Phebra is owned by an Australian manufacturer which is committed to supplying over 65 medicines in critical therapeutic areas. They are providing skills development and employment opportunities in the field of research. Phebra collaborates with the hospitals in developing sought-after therapeutic solutions. They also supply and out licenses product around the globe in the region such as the Pacific region, Asia, Europe, Canada, South Americas, and the middle east as well. A new sterile manufacturing plant got officially opened in March 2013 by Phebra and they even offer a large range of sterile injectable pharmaceuticals which got manufactured in their facility in Sydney and Australia.  Other pharmaceuticals are under the contract with Phebra because of which they develop and manufacture products on their behalf. The facility of Phebra is licensed by the Australian Therapeutic Goods Administration (TGA) and is compliant with Good Manufacturing Process (GMP). Phebra even started implementing a wide range of energy innovative efficient initiatives so as to reduce their carbon footprints. So, Phebra ultimately enables all-important development programs and also play the role of providing employment for scientist and medical researchers. Thus, Phebra is a clear example of how a manufacturing unit should be: with a lot of employment opportunities as well as improvised mechanisms to reduce the burden over the environment.